Author:
Wang Li,Huang Shanlong,Zhang Peng,Li Hongliang,Li Zhaolun,Xue Li,Wang Zhenlong,Chen Qi,Fu Delai,Luo Qidong,Li Hecheng
Funder
Wu Jieping Medical Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference17 articles.
1. Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Komura K, Uehara H, Minami K, Yamamoto K, Narumi Y (2019) Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer. Int J Oncol 54(1):167–176
2. Blinova E, Buzdin A, Enikeev D, Roshchin D, Suntsova M, Samyshina E, Drobyshev A, Deryabina O, Demura T, Blinov D (2020) Prognostic role of FGFR3 expression status and tumor-related microRNAs level in association with PD-L1 expression in primary luminal non-muscular invasive bladder carcinoma. Life 10(11):305
3. Goodyear MD, Krleza-Jeric K, Lemmens T (2007) The declaration of Helsinki. BMJ 335:624–625
4. Han MA, Maisch P, Jung JH, Hwang JE, Narayan V, Cleves A, Hwang EC, Dahm P (2021) Intravesical gemcitabine for non-muscle invasive bladder cancer: an abridged cochrane review. Investig Clin Urol 62(6):623
5. Hugar LA, Gilbert SM, Sexton WJ, Kamat AM, Li R (2021) Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer. Curr Opin Urol 31(2):160–169
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献